Aminoglycosides are a group of antibiotics used since the 1940s to primarily treat a broad
spectrum of bacterial infections. The primary resistance mechanism against these antibiotics …

Neonatal sepsis causes up to an estimated 680,000 deaths annually worldwide,
predominantly in low-and middle-income countries (LMICs). A significant and growing …

Antimicrobial resistance (particularly through extended-spectrum β-lactamase and
aminoglycoside-modifying enzyme production) in neonatal sepsis is a global problem …

Antibiotic, analgesic sedative, and antiseizure medications are among the most commonly
used medications in preterm/sick neonates, who are at high risk of nosocomial infections …

Background Annual mortality from neonatal sepsis is an estimated 430 000–680 000 infants
globally, most of which occur in low-and middle-income countries (LMICs). The WHO …

Background: Jaundice may be one of the first signs of urinary tract infection (UTI) in infants.
The most common pathogen is Escherichia coli. Currently recommended antibiotic treatment …

Purpose: This scoping review aims to map the effects of dosage levels, dosage intervals,
duration of exposure, and serum concentration levels of gentamicin, amikacin, vancomycin …

Background: Antibiotics are potent drugs which are usually used in the treatment of bacterial
infections. Aminoglycosides are powerful, broad spectrum antibiotics that exhibits both gram …

Los antimicrobianos son los medicamentos más utilizados en los neonatos durante su
primer mes de vida cuando se encuentran en unidades neonatales, principalmente por el …

Amikacin is an aminoglycoside antibiotic with a broad-spectrum bacterial coverage that is
frequently utilized both as monotherapy and in combination with other antibiotics for severe …